Patents by Inventor Gilbert Gaudel

Gilbert Gaudel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INJECTABLE OR ORALLY DELIVERABLE FORMULATIONS OF AZETIDINE DERIVATIVES
    Publication number: 20100022501
    Abstract: The invention concerns injectable or orally deliverable binary or ternary formulations of azetidine derivatives. The azetidine derivatives used in the inventive pharmaceutical compositions can be represented by the general formulae (Ia) or (Ib), wherein Ar is an aromatic or heteroaromatic group optionally substituted by one or more among (C1-C4)alkyl, halogen, NO2, CN, (C1-C4) alkoxy or OH.
    Type: Application
    Filed: October 5, 2009
    Publication date: January 28, 2010
    Applicant: AVENTIS PHARMA SA
    Inventors: Maria-Teresa PERACCHIA, Gilbert GAUDEL, Sophie COTE
  • SELF-EMULSIFYING AND SELF-MICROEMULSIFYING FORMULATIONS FOR THE ORAL ADMINISTRATION OF TAXOIDS
    Publication number: 20090069411
    Abstract: The present invention relates to novel formulations of taxoids for oral administration. More particularly, the present invention discloses and claims self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids.
    Type: Application
    Filed: September 26, 2008
    Publication date: March 12, 2009
    Applicant: AVENTIS PHARMA S.A.
    Inventors: Maria-Teresa PERACCHIA, Sophie COTE, Gilbert GAUDEL
  • INJECTABLE OR ORALLY DELIVERABLE FORMULATIONS OF AZETIDINE DERIVATIVES
    Publication number: 20070244085
    Abstract: The invention concerns injectable or orally deliverable binary or ternary formulations of azetidine derivatives. The azetidine derivatives used in the inventive pharmaceutical compositions can be represented by the general formulae (Ia) or (Ib), wherein Ar is an aromatic or heteroaromatic group optionally substituted by one or more among (C1-C4)alkyl, halogen, NO2, CN, (C1-C4) alkoxy or OH.
    Type: Application
    Filed: May 29, 2007
    Publication date: October 18, 2007
    Applicant: AVENTIS PHARMA SA
    Inventors: Maria-Teresa PERACCHIA, Gilbert GAUDEL, Sophie COTE
  • Self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids
    Publication number: 20050025792
    Abstract: The present invention relates to novel formulations of taxoids for oral administration. More particularly, the present invention discloses and claims self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids.
    Type: Application
    Filed: July 19, 2004
    Publication date: February 3, 2005
    Applicant: Aventis Pharma S.A.
    Inventors: Maria-Teresa Peracchia, Sophie Cote, Gilbert Gaudel
  • Glycosylated prodrugs, their method of preparation and their uses
    Patent number: 5561119
    Abstract: Glycosylated prodrugs, a preparation method therefor, and their use with tumor-specific immunoenzymatic conjugates for the treatment of cancer, are described. These anthracycline prodrugs have formula (I).
    Type: Grant
    Filed: May 27, 1994
    Date of Patent: October 1, 1996
    Assignees: Laboratoires Hoechst, Behringwerke A.G.
    Inventors: Jean-Claude Jacquesy, Jean-Pierre Gesson, Claude Monneret, Martine Mondon, Brigitte Renoux, Jean-Claude Florent, Michel Koch, Fran.cedilla.ois Tillequin, Hans H. Sedlacek, Manfred Gerken, Cenek Kolar, Gilbert Gaudel, Klaus Bosslet, J org Czech, Dieter Hoffman, Gerhard Seemann, Hans-Ulrich Schorlemmer, Gerhard Dickneite